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ABSTRACT 5-HT3 receptors demonstrate signiﬁcant structural and functional homology to other members of the Cys-loop
ligand-gated ion channel superfamily. The extracellular domains of these receptors share similar sequence homology (;20%)
with Limnaea acetylcholine binding protein, for which an x-ray crystal structure is available. We used this structure as a template
for computer-based homology modeling of the 5-HT3 receptor extracellular domain. AutoDock software was used to dock 5-HT
into the putative 5-HT3 receptor ligand-binding site, resulting in seven alternative energetically favorable models. Residues
located no more than 5 A˚ from the docked 5-HT were identiﬁed for each model; of these, 12 were found to be common to all
seven models with ﬁve others present in only certain models. Some docking models reﬂected the cation-p interaction previously
demonstrated for W183, and data from these and other studies were used to deﬁne our preferred models.
INTRODUCTION
The 5-HT3 receptor is a member of the Cys-loop family
of LGIC. This family of proteins, which includes nACh,
GABAA, and glycine receptors, are responsible for fast sy-
naptic transmission at chemical synapses and are the target
sites of many neuroactive drugs; however, we do not yet
know the molecular details of their structure. The receptors
are pentamers, and are usually constituted of 2–4 different
subunits; each subunit has a large extracellular N-terminal
region and four putative transmembrane domains (M1–M4).
Two 5-HT3 receptor subunits, A and B, have been char-
acterized (see Reeves and Lummis, 2002, for review), and
receptors appear to be able to function as either homo-oli-
gomeric (A only) or hetero-oligomeric (A and B) subunit
complexes (Davies et al., 1999). 5-HT3 receptors have been
proposed to be evolutionarily the oldest members of the Cys-
loop LGIC family, and this, combined with the ability of
these receptors to function as homo-oligomers, has meant that
5-HT3 receptors provide a useful model system for under-
standing critical features of all Cys-loop receptors (Reeves
and Lummis, 2002). Most work to date on this family of
proteins has been performed using nACh receptors, yet
despite many years of study, structural details of the protein-
ligand interactions at the molecular level remained unknown.
Evidence from early biochemical and mutagenesis studies on
nACh receptors indicated that it was the extracellular domain
that contained the ligand-binding site, a hypothesis that was
later conﬁrmed by the construction of a chimaeric protein
consisting of the N-terminal domain of thea7 neuronal nACh
receptor subunit linked to the C-terminal portion of the
5-HT3A receptor subunit: the resulting chimera possessed
nACh receptor pharmacological properties and 5-HT3 re-
ceptor channel properties (Eisele´ et al., 1993). The de-
termination of the structure of the AChBP (Brejc et al., 2001),
which is homologous not only to the extracellular domain of
the nACh receptor but also to those of other LGIC including
the 5-HT3 receptor, allows deﬁnition of the ligand-binding
domain at a greater level of detail than before.
Computer-aided modeling of the extracellular domain of
5-HT3 receptor has been attempted previously (Menziani
et al., 2001; Gready et al., 1997), but the structure of AChBP
suggests that these models may not reﬂect the true binding
site. Several homology-based models of the nACh recep-
tor and GABAA receptor have been recently constructed
(Le Nove`re et al., 2002; Cromer et al., 2002; Schapira et al.,
2002). In this paper, we present a model of the 5-HT3 re-
ceptor extracellular domain constructed by homology with
AChBP, and discuss the accuracy of the alternative docking




A sequence alignment of the extracellular domain of the 5-HT3 receptor and
AChBP was generated using the program FUGUE (Shi et al., 2001), which
utilizes environment-speciﬁc substitution tables and structure-dependent gap
penalties.
Modeling
The three-dimensional model of the extracellular region of the 5-HT3
receptor was built using MODELLER (Sali and Blundell, 1993) based on
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the crystal structure of AChBP determined to 2.7 A˚. The pentamer was
generated by superimposing the model onto each protomer of AChBP;
special care was taken not to alter the coordinate axes of reference. The
generated pentamer model was then energy minimized in SYBYL using the
AMBER force ﬁeld (Weiner et al., 1984) by moving side chains alone, to
relieve short contacts at the interprotomer interfaces. Electrostatic terms
were also included in these minimization cycles.
Ligand docking
The structure of 5-HT was constructed with idealized geometry using
MacroModel (Mohamadi et al., 1990), with hydrogen atoms added
assuming a pH of 7. The resultant structure, together with the modeled 5-
HT3R, were used as input for AutoDock 3.05 (Goodsell and Olson, 1990;
Morris et al., 1998). The number of points used in each Cartesian direction
was 60, thus giving a spacing of 0.375 A˚ and a total of 216,000 points. The
grid center was manually set to an arbitrary point within the binding site
space. Ten genetic algorithm runs were performed on each docking exercise,
with a population size of 50, and the maximum number of generations was
set to 27,000. Seven docked structures were obtained. These structures were
then used as input for a program written by one of us (P.-L.C.) to extract all
amino acids that possess at least one atom within 5 A˚ of the 5-HT ligand.
Potential hydrogen-bonding interactions were identiﬁed using SwissPDB-
Viewer (Guex and Peitsch, 1997). Hydrogen bonds between 1.20 and 2.76 A˚
were allowed with a minimum angle of 1208. Figures were rendered using
POV-Ray 3.1 for Macintosh.
RESULTS
The sequence identity between the 5-HT3 receptor ECD and
AChBP, as shown in Fig. 1, is relatively low (19% for the a-
subunit), although this value is similar to that between
AChBP and ACh receptor subunit ECDs (an average of
22%). However, the predicted secondary structure of
a typical nACh subunit ECD has 61.2% identity with
AChBP, and it has been calculated that the secondary
structure similarity between AChBP and the a7 nACh
receptor subunits is around 80% (Le Nove`re et al., 2002).
Thus the secondary structure of the closely related 5-HT3
receptor ECD, and indeed all Cys-loop LGIC ECDs, is likely
to be well represented by the AChBP structure. Our model of
the 5-HT3 receptor extracellular domain therefore adopts an
immunoglobulin-like fold similar to that found for AChBP
(Grutter and Changeux, 2001).
The actual location of the agonist-binding site in AChBP
has not been ﬁnally determined, as the structure has not
yet been crystallized with ACh bound. However, a HEPES
molecule was identiﬁed in the putative binding pocket. As
this molecule has a charged amine like ACh, and the residues
associated with the binding site were those previously
described from labeling and mutagenesis studies, it seems
highly likely that this will prove to be the binding pocket
of the protein. This region, which is located at the subunit
interfaces, is indicated in Fig. 2 A. The relative orientations
of loops A–E, all of which contribute to the binding site in
our models, are shown in Fig. 2 B.
The model of the binding site of 5-HT can be described as
a cleft with a predominance of aromatic residues. Of these,
F226 and W90 are toward the membrane or lower side of
the cleft, whereas W183, Y234, and Y143 are toward the top
of the cleft and therefore would be closer to the presynaptic
cell. The docking procedure resulted in seven energetically
favorable models for positioning 5-HT in this binding site.
In models 1–3 (Fig. 3), 5-HT is oriented such that the pri-
mary amine is in the lower part of the cleft, with the rings of
5-HT sandwiched between the aromatic rings of Y234 and
W183, and there is the potential to form a hydrogen bond
with the main chain carboxyl of S182. The hydroxyl of 5-HT
appears to be in a hydrophilic pocket formed by R92, D229,
and Q151. The models differ in having subtle variations in
the locations of the primary amine and the rings in the cleft,
and this is reﬂected in the different lengths of the potential
hydrogen bond with S182: for model 1, 2.4 A˚; for model 2,
2.6 A˚; and for model 3, 2.2 A˚.
In models 4 and 5 (Fig. 3), 5-HT is oriented such that the
rings are at the lower part of the cleft and the primary amine
is between W183 and Y234. The hydroxyl group is located
in a hydrophilic pocket formed by T179, E236, and N128,
with the potential to form hydrogen bonds with the latter
two. There is also the potential to form a third hydrogen bond
with the main chain carboxyl of S182 (of 2.0 A˚, model 4) or
W183 (of 2.3 A˚, model 5). Models 4 and 5 differ by subtle
changes in the location of the primary amine—in model 4,
the nitrogen is 4.1 A˚ from the nearest carbon of the Y234
ring and 4.8 A˚ from the nearest carbon of the W183 benzene
ring, whereas in model 5 the distances are 3.9 A˚ and 5.2 A˚,
respectively. There is also a difference in the twist of the
rings, which would result in different length hydrogen bonds
FIGURE 1 Alignment of the amino acid sequence of the extracellular
domain of the 5-HT3A receptor subunit with that of AChBP. The alignment
is annotated using the program JOY (Mizuguchi et al., 1998). Key to
alignment: a-helix, red x; b-strand, blue x; 310 helix, maroon X; solvent
accessible, lower case X; solvent inaccessible, upper case X; hydrogen bond
to main-chain amide, boldface X; hydrogen bond to main-chain carbonyl,
underlined X; disulﬁde bond, cedilla c¸; positive f-torsion angle, italic X.
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with the keto group of N128 (2.8 A˚ and 2.5 A˚ for models
4 and 5, respectively).
In model 6, the indole N atom of 5-HT is toward the top of
the cleft, and is similarly located in model 7, although here
5-HT has rotated;1808. The primary amines are therefore at
quite distinct locations at either upper right of the cleft with
the N atom 3.2 A˚ from the nearest atom of Y143 (model 6),
or to the lower left at a distance of 3.7 A˚ from the nearest
atom of F226 (model 7). The hydroxyl groups, however, are
both located close to Y153: in model 6 there is the potential
to form a hydrogen bond of length 2.3 A˚, whereas in model 7
it is 3.3 A˚ from the nearest carbon atom. The former is the
only potential hydrogen bond we identiﬁed in model 6, and
in model 7 there is also only one potential hydrogen bond,
between the indole N atom and the backbone carbonyl of
S182.
DISCUSSION
We have used information available from the x-ray crystal
structure of AChBP to model the extracellular domain of
the 5-HT3 receptor. This region contains the binding sites for
5-HT, which lie at the subunit interfaces. Simulated docking
of 5-HT with our model of the binding site using the pro-
gram AutoDock revealed seven energetically favorable posi-
tions of 5-HT. Examination of the residues within 5 A˚ of
5-HT showed that many (12 out of 17) were common to
all positions (see Table 1), and most of these residues, as
expected, fall in the binding loop regions that have been
proposed to constitute the binding site (Fig. 2 B). Our data
also identify residues that have the potential to form
hydrogen bonds with the agonist, and therefore may be
involved not only in its correct localization but also in
transducing agonist binding into channel opening. The
results show that homology modeling can be valuable in
locating residues involved in agonist binding, and in pro-
viding experimentally testable hypotheses to characterize
agonist-receptor interactions.
AChBP is homologous to the extracellular domain of the
Cys-loop family of LGIC and therefore, given that there are
as yet no atomic resolution structures of the latter proteins,
homology modeling with AChBP provides a route to iden-
tifying important features of the extracellular domain. It
should be remembered, however, that AChBP lacks many
features of the complete receptor and therefore the lim-
itations of such data must be borne in mind. For example,
combining structural information from this protein with the
highest available resolution images from the nACh receptor
has revealed that in the absence of ACh, the extracellular
domains of the a-(ligand-binding) subunits differ by rota-
tions of their inner pore-facing parts when compared to the
AChBP subunit structures (Unwin et al., 2002). As the struc-
ture of AChBP does, however, appear to provide a reason-
able ﬁt with the nACh receptor data in the presence of ACh,
the use of the model we have derived to examine the docking
of 5-HT should yield a sufﬁciently accurate estimation of
the agonists’ location to provide useful experimentally test-
able hypotheses. Indeed, the residues that we identiﬁed as
\5 A˚ from 5-HT are all located in the binding loops
A–E that were originally deﬁned from photo-afﬁnity label-
ing and mutagenesis studies of the related nACh receptor.
These studies showed that residues contributing to the bind-
ing site were located in three regions of the a-subunit (loops
A–C) and three regions on the adjacent b- or g-subunit
(loops D–F), although the latter appeared to play a less sig-
niﬁcant role. Consistent with these data, examination of
the putative ligand-binding pocket of the 5-HT3 receptor sug-
gests that residues from the loop B and C regions play the
major role, with fewer residues from loops A, D, and E being
involved. Loop F has not yet been fully deﬁned in the
structure of AChBP, and thus we currently have no loop F
residues in our model.
To identify which of the docking positions is most likely to
represent the correct orientation of 5-HT in the binding site,
we used both experimental data and evidence from sequence
conservation. The latter is indicated in Table 1 and shows that
76% of the residues we identiﬁed to be within 5 A˚ of 5-HT are
conserved in all agonist-binding 5-HT3 receptor subunits
identiﬁed to date. The only region that contains residues that
are not conserved is loop C. As we would anticipate that
critical residues would be conserved, models 4 and 5 are
favored; here only two nonconserved residues are present in
the binding site, as compared to four in the other models.
Conversely, comparing those residues that are conserved but
are not present in our deﬁned binding site region, the most
likely models are 4, 5, and 7 (one residue not present),
whereas in the other models two residues are not present.
More deﬁnitive evidence, however, can be obtained from
FIGURE 2 Homology model of the 5-HT3 receptor
extracellular domain. (A) Model of 5-HT3 receptor based
on AChBP showing the location of the putative ligand-
binding pocket. The white arrow points perpendicular to
the membrane in the plane of the ion channel away from
the membrane. (B) The ﬁve ligand-binding loops A–E for
5-HT3 receptor as deﬁned for the nACh receptor. Key:
loop A (yellow); loop B (blue); loop C (green); loop D
(red); loop E (gray).
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experimental studies. The most useful of these are probably
by the Lester lab, who have shown that the 18 amine of 5-HT
forms a cation-p interaction with W183 in the binding site
(Beene et al., 2001). Mutagenesis studies have previously
shown that this tryptophan is a critical ligand-binding residue
(Spier and Lummis, 2000), and it is homologous to W149
in the nACh receptor, which also is involved in a cation-p
interaction with the agonist (Zhong et al., 1998). In other
LGIC this residue also appears important; aromatic residues
are found in the homologous position in GABAA and glycine
receptors, where again they have been shown to play a role in
ligand binding (Schmieden et al., 1993; Vandenberg et al.,
1992; Amin and Weiss, 1993). These data favor models 4
and 5 and indeed allow us to dismiss models 6 and 7, where
the aromatic center of tryptophan is not sufﬁciently close to
the 18 amine of 5-HT to form such an interaction (Gallivan
and Dougherty, 1999).
W183 is located in the loop B region. Our models suggest
that up to four other residues from this region are also in the
binding site: T181, S182, and L184 were observed in all
models, and T179 in models 4 and 5. T179 is conserved not
only in all agonist binding (A) subunits, but also in B and in
the recently identiﬁed but as yet uncharacterized C subunits
(Reeves and Lummis, 2002), but not in the nACh receptor
or in AChBP. This suggests it may play an important role,
further supporting models 4 and 5. Potential hydrogen bonds
with some of these loop B residues also provide a useful
experimentally testable point of distinction between these
two models. In model 4, the backbone carboxyl group of
S182 is an appropriate distance and orientation to form
a hydrogen bond with primary amine of 5-HT, whereas in
model 5 a hydrogen bond could form with the backbone
carboxyl group of W183 (Fig. 3).
In loop A, the only residue within 5 A˚ of 5-HT is N128.
This residue has not been previously identiﬁed as a ligand-
binding residue, but interestingly the adjacent glutamate,
E129, and also F130 have been proposed from mutagenesis
studies to be involved in both agonist and antagonist binding
(Steward et al., 2000). It is possible that changing these
residues alters the location or orientation of N128. It is also
possible, however, that our alignment may not be accurate in
this region. Further mutational analysis will be required to
distinguish between these possibilities.
Experimental evidence has also shown that loop C resi-
dues play a critical role in forming the binding site. Simulta-
neous mutagenesis of I228, D229, and I230 signiﬁcantly
changed the EC50 for 5-HT, although the single mutations
have yet to be investigated (Hope et al., 1999). D229 is
one of two acidic residues in the loop C region, and there
is evidence that at least one of these is in close proxi-
mity to the ligand. The ﬂuorescence proﬁle of the 5-HT3 re-
ceptor antagonist, GR-ﬂu, is pH dependent, and when bound
suggests an acidic character for the binding site (Tairi et al.,
1998). Interestingly, D229, which is in the binding site in
models 1, 2, 3, 6, and 7, is not conserved in all binding sub-
units. This is in contrast to E236, which is present in models
4, 5, and 7; thus, sequence data support the latter models.
Y234 has also been shown in mutagenesis experiments
to play a role at the binding site (Price and Lummis, 2001),
perhaps in stabilizing the primary amine of 5-HT. In models
4 and 5 it is located at the opposite side of this amine group
to W183 and may form another cation-p interaction here.
Other mutagenesis studies of the loop C region also sug-
gest that a number of these residues are involved in ligand
binding; this region was found to be critical in controlling
the potency of both the 5-HT3 receptor agonist meta-chloro-
phenylbiguanide (Mochizuki et al., 1999) and the antagonist
d-tubocurarine (Yan et al., 1999).
In loop D, two residues appear in all our models, W90
and R92, and there are experimental data from mutagenesis
studies to support their role in the binding site (Mochizuki
et al., 1999; Yan et al., 1999). These residues correspond to
ligand-binding residues W53 and Q55 in the AChBP, which,
as predicted by Yan et al. (1999) for the 5-HT3 receptor, are
part of a b-sheet structure in our model.
Two residues from loop E are also apparent in all our
FIGURE 3 Docking models for the binding of 5-HT to the 5-HT3 receptor (1–7). Models 1–7, respectively, of 5-HT docked in the receptor binding site.
Amino acids shown in each case project within a 5 A˚ radius of 5-HT. 5-HT is shown for clarity in a space-ﬁlling view, but these radii are not to scale. The
protein is displayed in the same 3D orientation in each panel. Potential hydrogen bonds are shown as dotted green lines (lengths given in text). All other atoms
are colored according to the CPK system (blue, nitrogen; red, oxygen; white, carbon).
TABLE 1 Residues of the putative 5-HT3 receptor binding
site within 5 A˚ of 5-HT
5-HT3A Model
a1 nAChR
Loop Residue 1 2 3 4 5 6 7 CON Residue
A N128 1 1 1 1 1 1 1 y Y93
B T179    1 1   y K145
T181 1 1 1 1 1 1 1 y G147
S182 1 1 1 1 1 1 1 y T148
W183 1 1 1 1 1 1 1 y W149
L184 1 1 1 1 1 1 1 y T150
C F226 1 1 1 1 1 1 1 y Y190
I228 1 1 1 1 1 1 1 n C192
D229 1 1 1   1 1 n C193
I230 1 1 1   1 1 n P194
Y234 1 1 1 1 1 1 1 n* Y198
E236    1 1  1 y D200
D W90 1 1 1 1 1 1 1 y R55
R92 1 1 1 1 1 1 1 y K57
E Y143 1 1 1 1 1 1 1 y L79
Q151 1 1 1   1 1 y T117
Y153 1 1 1 1 1 1 1 y T119
CON, conservation of this residue in all known 5-HT3A (agonist-binding)
subunits to date. Bold indicates experimental evidence is available to sup-
port the role of this residue in the ligand-binding site. Equivalent residues
in a nACh receptor subunit are shown for comparison.
*, conserved as aromatic.
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models: Y143 and Y153. These data are also supported by
mutagenesis studies that show changes in antagonist afﬁnity
when these tyrosines are replaced by serine or alanine (Price
and Lummis, 2001). A separate systematic study of loop E
of the 5-HT3 receptor using radioligand binding also strongly
implicates these tyrosines in ligand binding (Venkataraman
et al., 2002). Q151 appears to be part of the binding site in
models 1 and 6; however, there is currently no experimental
evidence to support a role for this residue.
No residues from loop F are found in our models, as found
in a ligand-docked model of the nACh receptor (Le Nove`re
et al., 2002). As our model is not dynamic like the receptor
itself, it may be that loop F plays a role in the binding site in
states not represented by our model.
Models 1, 2, 3, 6, and 7 all display one potential hydrogen-
bonding interaction with 5-HT, whereas models 4 and 5
have three positions for potential hydrogen bonds: with the
backbone of S182 and the functional groups of E236 and
N128. Not only would this favor tight binding of 5-HT in
these two models, but also it is supported by an experi-
mentally derivedmodel of the pharmacophore for partial ago-
nists (Daveu et al., 1999). This pharmacophore identiﬁes two
important hydrogen-bonding interactions at opposite ends
of the ligand, which resemble those shown by models 4 and
5 described above. It is also interesting that these three po-
tential hydrogen bonds are all in the one half of the cleft,
which, according to the work of Unwin et al. (2002), would
rotate on addition of agonist compared to the opposite side
(which in our model is in the lower half, from residues W90
to Y143). Thus these hydrogen bonds could contribute to
lowering the energy barrier for channel opening.
To date, two models of the nACh receptor binding site (Le
Nove`re et al., 2002; Schapira et al., 2002) and one of the
GABAA receptor binding site (Cromer et al., 2002) similarly
based on the structure of AChBP have been published.
Although many of the residues in the ligand-binding site
are equivalent, the details differ signiﬁcantly between the
models. For example, Schapira et al. (2002) invoke a water
molecule in the binding site between a hydrophilic pocket
formed by loops B and C and the region of the ligands distal
to the ammonium of ACh. This water is not found in a similar
model (Le Nove`re et al., 2002). It is notable that both these
models propose that the charged nitrogen of either ACh
or nicotine intercalates between W148 and Y194. If the
mechanisms of agonist binding are conserved between
nACh and 5-HT3 receptors, which seems a reasonable as-
sumption, then we might expect that the charged nitrogen
of 5-HT would be similarly located between a tryptophan
and a tyrosine residue. This is indeed the case for models 4
and 5, and, therefore, assuming that one of these models is
correct, it distinguishes the 5-HT binding mechanism of the
ligand-gated 5-HT3 receptor from that of the six known
metabotropic 5-HT receptors. Here, models suggest that the
indole group of 5-HT binds in a hydrophobic pocket formed
by tryptophan and tyrosine residues, and that the charged
primary amine is compensated by polar or charged residues,
not via a cation-p interaction (Manivet et al., 2002). This
supports the idea that metabotropic and ionotropic 5-HT
receptors evolved independently, and therefore it is not sur-
prising that different binding mechanisms exist for each
receptor type.
Thus, overall, our data favor models 4 and 5. They are
supported by both sequence-alignment data and experi-
mental evidence. These two models only differ by a small
rotation of 5-HT. However, as described above, the in-
volvement of different hydrogen bonds in the two models
should make distinguishing between them experimentally
feasible. This ability to determine the accuracy of the models
by experimentation is extremely important as has been dem-
onstrated both by the production of two different models of
the nACh receptor based on homology modeling, and by
the demonstration that the ligand-binding subunits of the
receptor may rotate on agonist binding. In addition, our
models identify several residues, such as N128, S182, and
E236, which may play important but as yet uncharacterized
roles in ligand binding. Mutation of these residues will allow
further reﬁnement and a posteriori evaluation of the binding
site models.
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